中华皮肤科杂志 ›› 2016, Vol. 49 ›› Issue (2): 82-87.

• 论著 • 上一篇    下一篇

T细胞免疫球蛋白黏蛋白分子3对黑素瘤TRP-2180-188肽疫苗刺激小鼠淋巴细胞的影响

吕雅琳1,周晓伟1,胡彬1,吴琼1,曾学思2,刘毅1,孙建方2   

  1. 1. 中国医学科学院北京协和医学院皮肤病研究所
    2. 南京 中国医学科学院北京协和医学院皮肤病研究所
  • 收稿日期:2015-05-11 修回日期:2015-11-22 出版日期:2016-02-15 发布日期:2016-02-04
  • 通讯作者: 孙建方 E-mail:fangmin5758@aliyun.com
  • 基金资助:

    国家自然科学基金面上项目;江苏省自然科学基金面上项目;2012高等学校博士学科点专项科研基金

Effect of T-cell immunoglobulin and mucin domain-3 on TRP-2180-188 peptide-stimulated murine spleen lympho-cytes co-cultured with B16F10 murine melanoma cells

  • Received:2015-05-11 Revised:2015-11-22 Online:2016-02-15 Published:2016-02-04

摘要:

目的 探讨体外T细胞免疫球蛋白黏蛋白分子-3(TIM-3)对与小鼠黑素瘤B16F10细胞共培养的酪氨酸相关蛋白-2(TRP-2180-188)抗原肽刺激小鼠淋巴细胞的影响。 方法 构建TIM-3重组质粒pFUSE-TIM-3-mIgG2Aae1-Fc2,分别转染重组质粒及空质粒pFUSE-mIgG2Aae1-Fc2至人上皮293T细胞,继续培养48 h,制备含TIM-3、免疫球蛋白(Ig-tail)的上清液。TRP-2180-188肽疫苗免疫C57BL/6小鼠,分离小鼠脾淋巴细胞,用TRP-2180-188抗原肽和白细胞介素(IL)-2刺激培养5 d,以未刺激细胞作为对照组。构建B16F10细胞与上述TRP-2180-188抗原肽刺激淋巴细胞共培养体系,分为空白对照组(加293T细胞培养48 h上清液)、TIM-3组(加含TIM-3上清液)、阴性对照组(加含Ig-tail上清液)。CCK-8法检测细胞增殖情况,酶联免疫吸附试验(ELISA)检测共培养体系中干扰素(IFN)-γ和肿瘤坏死因子(TNF)-α浓度,流式细胞仪检测共培养体系中CD8+T淋巴细胞。 结果 酶切和测序鉴定证实目的基因正确插入真核表达载体中,检测到转染重组质粒pFUSE-TIM-3-mIgG2Aae1-Fc2的293T细胞上清液中有TIM-3表达,转染空质粒pFUSE-mIgG2Aae1-Fc2的293T细胞上清液中有Ig-tail的表达。CCK-8法检测显示24 h时空白对照组、阴性对照组、TIM-3组淋巴细胞增殖活力分别为(100.00 ± 10.42)%、(108.70 ± 9.90)%、(78.06 ± 6.37)%,48 h时分别为(100.00 ± 6.24)%、(168.00 ± 2.98)%、(42.93 ± 5.93)%;24 h、48 h时TIM-3组淋巴细胞活力低于空白对照组和阴性对照组(均P < 0.05)。TIM-3组48 h相比24 h淋巴细胞增殖倍数低于空白对照组和阴性对照组(均P < 0.05)。24 h时,空白对照组、阴性对照组、TIM-3组IFN-γ浓度分别为(216.44 ± 7.85)、(223.67 ± 7.79)、(192.96 ± 5.05) ng/L,48 h时分别为(230.06 ± 4.23)、(167.24 ± 3.33)、(54.95 ± 0.57) ng/L。24 h、48 h时,TIM-3组IFN-γ浓度低于空白对照组和阴性对照组(均P < 0.05)。24 h、48 h时,TIM-3组TNF-α浓度低于空白对照组和阴性对照组(均P < 0.05)。24 h时空白对照组、阴性对照组、TIM-3组CD8+T淋巴细胞中位数分别为0.421%、2.22%、3.30%,48 h时分别为0.577%、0.691%、4.06%。24 h、48 h时TIM-3组CD8+T淋巴细胞中位数高于空白对照组和阴性对对照组。 结论 TIM-3在体外能够抑制B16F10细胞与TRP-2180-188抗原肽刺激淋巴细胞共培养体系中淋巴细胞增殖和分泌IFN-γ、TNF-α,提高CD8+T淋巴细胞。

Abstract:

Lyu Yalin, Zhou Xiaowei, Hu Bin, Wu Qiong, Zeng Xuesi, Liu Yi, Sun Jianfang Department of Pathology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China(Lyu YL, Hu B, Wu Q, Zeng XS, Liu Y, Sun JF); Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing 210042, China (Zhou XW) Corresponding authors: Liu Yi, Email: dr.liuyi@gmail.com; Sun Jianfang, Email: sunjf57@163.com 【Abstract】 Objective To evaluate the effect of T-cell immunoglobulin and mucin domain-3 (TIM-3) on TRP-2180-188 peptide-stimulated murine spleen lymphocytes co-cultured with B16F10 murine melanoma cells. Methods A recombinant plasmid pFUSE-TIM-3-mIgG2Aae1-Fc2 encoding TIM-3 was constructed. Then, the recombinant plasmid and an empty plasmid pFUSE-mIgG2Aae1-Fc2 were transfected into human 293T epithelial cells followed by 48-hour culture for the preparation of supernatants containing TIM-3 and Ig-tail respectively. C57BL/6 mice were immunized with the TRP-2180-188 peptide vaccine for 4 sessions. One week after the last vaccination, C57BL/6 mice were sacrificed, and spleen lymphocytes were collected and then cultured with the TRP-2180-188 peptide and interleukin-2 (IL-2) for 5 days, with lymphocytes untreated with the TRP-2180-188 peptide or IL-2 serving as the control group. Mitomycin-treated B16F10 murine melanoma cells and TRP-2180-188 peptide-stimulated lymphocytes were co-cultured with the presence of supernatants of 293T cells that had been cultured for 48 hours(blank control group), TIM-3-containing supernatants (TIM-3 group) and Ig-tail-containing supernatants (negative control group) separately. After 24 and 48 hours of co-culture, cell counting kit-8(CCK-8) assay was performed to estimate the proliferative activity of lymphocytes, enzyme-linked immunosorbent assay (ELISA) to determine the supernatant levels of interferon (INF)-γ and tumor necrosis factor (TNF)-α, flow cytometry to determine the percentage of CD8+ T cells in the co-culture system. Results Enzyme digestion and sequence analysis showed that the TIM-3 gene was successfully inserted into the eukaryotic expression plasmid. After 48-hour culture, TIM-3 and Ig-tail expressions were detected in the supernatants of 293T cells transfected with the recombinant plasmid and empty plasmid respectively. As CCK-8 assay showed, the proliferative activity of lymphocytes was significantly lower in the TIM-3 group than in the blank control group and negative control group after 24- and 48-hour culture (78.06% ± 6.37% vs. 100.00% ± 10.42% and 108.70% ± 9.90% at 24 hours, 42.93% ± 5.93% vs. 100.00% ± 6.24% and 168.00% ± 2.98% at 48 hours, all P < 0.05), so was the ratio of cellular proliferative activity at 48 hours to that at 24 hours (all P < 0.05). Compared with the blank control group and negative control group, the TIM-3 group showed significantly decreased supernatant levels of IFN-γ and TNF-α after 24-hour (IFN-γ: 192.96 ± 5.05 ng/L vs. 216.44 ± 7.85 ng/L and 223.67 ± 7.79 ng/L, both P < 0.05; TNF-α: 58.43 ± 0.26 ng/L vs. 26.43 ± 0.01 ng/L and 86.85 ± 1.12 ng/L, both P < 0.05) and 48-hour culture (IFN-γ: 54.95 ± 0.57 ng/L vs. 230.06 ± 4.23 ng/L and 167.24 ± 3.33 ng/L, both P < 0.05; TNF-α: 30.23 ± 0.26 ng/L vs. 26.84 ± 0.20 ng/L and 45.34 ± 0.22 ng/L, both P < 0.05). In addition, the median percentage of CD8+ T cells was significantly increased in the TIM-3 group compared with the blank control group and negative control group after 24- and 48-hour culture (3.30% vs. 0.421% and 2.22% at 24 hours, 4.06% vs. 0.577% and 0.691% at 48 hours, all P < 0.05). Conclusion TIM-3 in vitro can suppress the proliferative activity of and secretion of IFN-γ and TNF-α by lymphocytes, but increase the percentage of CD8+ T cells in the co-culture system of TRP-2180-188 peptide-stimulated lymphocytes and B16F10 cells.